MPC-9528

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameMPC-9528

Drug Alias NameNAMPRT modulator (Myrexis)nicotinamide phosphoribosyltransferase modulator (Myriad)NAMPRT modulator (Myriad)nicotinamide phosphoribosyltransferase modulator (Myrexis)MPI-0486348 +[6]

ClassificationSmall molecules

Mechanisms of ActionNicotinamide phosphoribosyltransferase inhibitors

TargetsNicotinamide phosphoribosyltransferase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMyrexis Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMyrexis Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A